We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$231B
AUM Growth
+$33B
Cap. Flow
+$7.99B
Cap. Flow %
3.46%
Top 10 Hldgs %
20.51%
Holding
6,891
New
816
Increased
2,304
Reduced
2,388
Closed
883

Sector Composition

Rank Sector Weight
1 Technology 8.34%
2 Healthcare 6.09%
3 Financials 5%
4 Consumer Discretionary 4.53%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLLIW
5901
CALL
DELISTED
Globalink Investment Inc. Warrants
GLLIW
$99 ﹤0.01%
30,000
FAZEW
5902
CALL
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$98 ﹤0.01%
22,833
AENTW icon
5903
CALL
Alliance Entertainment Holding Corp Warrants
AENTW
$2.84M
$94 ﹤0.01%
12,500
NBIS
5904
Nebius Group N.V.
NBIS
$57.3B
$87 ﹤0.01%
874,278
GSDWW
5905
CALL
DELISTED
Global Systems Dynamics, Inc. Warrant
GSDWW
$59 ﹤0.01%
12,500
ABCL icon
5906
CALL
AbCellera Biologics
ABCL
$3.44B
-250,000
Closed -$1.15M
ABEO icon
5907
CALL
Abeona Therapeutics
ABEO
$347M
-42,900
Closed -$181K
ABOS icon
5908
CALL
Acumen Pharmaceuticals
ABOS
$223M
-53,800
Closed -$223K
ACAD icon
5909
CALL
Acadia Pharmaceuticals
ACAD
$5.11B
-384,500
Closed -$8.01M
ACAD icon
5910
PUT
Acadia Pharmaceuticals
ACAD
$5.11B
-130,900
Closed -$2.73M
ACES icon
5911
ALPS Clean Energy ETF
ACES
$113M
-58,751
Closed -$2.15M
ACGL icon
5912
PUT
Arch Capital
ACGL
$34.5B
-15,100
Closed -$1.2M
ACHC icon
5913
CALL
Acadia Healthcare
ACHC
$2.67B
-10,000
Closed -$703K
ACHC icon
5914
PUT
Acadia Healthcare
ACHC
$2.67B
-5,000
Closed -$352K
ACHV icon
5915
Achieve Life Sciences
ACHV
$817M
-23,605
Closed -$102K
ACLX
5916
CALL
DELISTED
Arcellx
ACLX
-10,000
Closed -$359K
ACRS icon
5917
CALL
Aclaris Therapeutics
ACRS
$929M
-57,400
Closed -$393K
ACRS icon
5918
PUT
Aclaris Therapeutics
ACRS
$929M
-100,000
Closed -$685K
ACXP icon
5919
Acurx Pharmaceuticals
ACXP
$6.02M
-729
Closed -$20.8K
ADT icon
5920
ADT
ADT
$5.42B
-12,400
Closed -$74.4K
AFCG
5921
AFC Gamma
AFCG
$78.2M
-27,521
Closed -$221K
AG icon
5922
CALL
First Majestic Silver
AG
$10.3B
-110,700
Closed -$568K
AG icon
5923
PUT
First Majestic Silver
AG
$10.3B
-25,300
Closed -$130K
AGL icon
5924
CALL
Agilon Health
AGL
$1.57B
-4,000
Closed -$1.78M
AGNC icon
5925
AGNC Investment
AGNC
$13B
-2,332,796
Closed -$20.5M

Similar funds

Israel Englander's Q4 2023 Portfolio in Review

As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Israel Englander deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.

  • Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
  • Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
  • Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
  • Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
  • Israel Englander opened 816 new positions and closed 883 in Q4 2023.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.